Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
to better understand, diagnose and treat diseases with particular interests in cancer and neurodegenerative diseases. We are a highly collaborative and multidisciplinary lab eager to create an impact on
-
. They should have solid knowledge of chemistry and biology, and an excellent command of spoken and written English and Chinese. Experience in bioinformatic data analysis including microbiome, virome and
-
. Applicants should possess a Ph.D. degree in Biomedical Engineering, Biochemistry, Cancer Immunology, Genomics, Bioinformatics, or a related field, and demonstrate exceptional experimental, writing, and
-
posts) [Appointment period: each for twelve months] Duties The appointees will assist the project leader in the research project - “Study on design and analysis of high-performance parallel manipulators
-
initiatives develop, coordinate, and manage clinical trials in alignment with regulatory standards draft and submit grant proposals to secure research funding apply bioinformatics, biostatistics, and
-
, molecular and cell biology, and animal models. Skills in bioinformatics are advantageous. Candidates should be highly motivated and have a track record of publications in international journals. The appointee
-
Bioinformatics, Computing/Programming, or a related discipline. Experience in using PMNN, ESM2 and RFdiffusion would be an advantage. The appointee will work in collaboration with research teams focusing
-
, preparing manuscripts, drafting and submitting competitive internal and external grants Perform other duties as assigned Requirements A Ph.D. degree with a strong research background in bioinformatics
-
will be given to candidates with research experience in cancer bioinformatics, cancer biology and/or cancer immunology; as well as cell/organoid culture, cellular/molecular biology, flow cytometry
-
, computer vision and graphics, and bioinformatics. Worldwide recognition ranking #25 & #37 worldwide in AI and CS respectively by U.S. News & World Report 2023; #29 worldwide in CS&E in ShanghaiRanking 2023